Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · Real-Time Price · USD
6.20
+0.03 (0.49%)
At close: Sep 28, 2026, 4:00 PM EDT
6.21
+0.01 (0.19%)
After-hours: Sep 28, 2026, 7:57 PM EDT
RGC Market Cap
RGC has a market cap or net worth of $3.07 billion as of September 28, 2026. Its market cap has decreased by -58.86% in one year.
Market Cap
3.07B
Enterprise Value
3.07B
1-Year Change
-58.86%
Ranking
Category
Stock Price
$6.20
ChartMarket Cap Chart
Since the IPO on July 16, 2021, RGC's market cap has increased from $120.10M to $3.07B, an increase of 2,457.82%. That is a compound annual growth rate of 86.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 28, 2026 | 3.07B | -70.42% |
| Dec 31, 2025 | 10.38B | 16,053.85% |
| Dec 31, 2024 | 64.28M | -52.95% |
| Dec 29, 2023 | 136.63M | -62.35% |
| Dec 29, 2022 | 362.93M | -12.12% |
| Dec 31, 2021 | 413.00M | 243.88% |
| Jul 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Amylyx Pharmaceuticals | 3.70B |
| HUTCHMED (China) | 2.49B |
| Supernus Pharmaceuticals | 2.48B |
| Trulieve Cannabis | 2.35B |
| Prestige Consumer Healthcare | 2.21B |
| BioCryst Pharmaceuticals | 2.20B |
| Perrigo Company | 2.14B |
| Bausch Health Companies | 2.13B |